MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.390
-0.030 (-2.11%)
At close: Aug 25, 2025, 4:00 PM
1.390
0.00 (0.00%)
After-hours: Aug 25, 2025, 4:00 PM EDT
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $147.65 million as of August 25, 2025. Its market cap has decreased by -65.56% in one year.
Market Cap
147.65M
Enterprise Value
39.60M
1-Year Change
-65.56%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $147.65M, a decrease of -70.15%. That is a compound annual growth rate of -23.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 151.38M | -65.57% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
| Mar 10, 2021 | 494.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |